Clinical Trial Update: Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 real-world evidence study on duration of effect for Adhansia XR in ADHD has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Adhansia XR (Extended-Release) (methylphenidate extended-release)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 4 | Status: TERMINATED | Results posted: 2023-07-27